Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Sonnet BioTherapeutics Holdings, Inc. | v232949_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 19, 2011
CHANTICLEER HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
000-29507
|
20-2932652
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification)
|
11220 Elm Lane, Suite 103, Charlotte, NC 28277
(Address of principal executive office) (zip code)
___________________________________________________
(Former address of principal executive offices) (zip code)
(704) 366-5122
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR240.13e-4(c))
ITEM 7.01 Regulation FD Disclosure
On August 19, 2011, Chanticleer Holdings, Inc. (the “Company”) issued a press release disclosing the extension of the expiration date of its rights offering from August 20, 2011 to September 10, 2011, and clarifying that the warrants issuable under the rights offering are transferable. A copy of the press release is attached hereto as Exhibit 99.1.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press Release dated August 19, 2011. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Chanticleer Holdings, Inc. | |||
|
August 19, 2011
|
By:
|
/s/ Michael D. Pruitt | |
|
Name: Michael Pruitt
|
|||
|
Title: Chief Executive Officer
|
|||
3